Showing results 1-10 of 43 for 'proteins'
Prof. Eran Hornstein discovered that a small molecule already on the market for a different disease can also be active in treating ALS. As Globes reports, NeuroSense Therapeutics will develop the technology; since ALS is considered a priority, NeuroSense believes that it will be able to bring the drug to market within five years.
WeizmannViews Issue No. 46 is about the research of new young scientist Dr. Rina Rosenzweig. She is expert in using super-powerful NMR machines, applying these skills to her studies of misfolded proteins and the clumps they form. These protein “aggregates” are involved in neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s.
Malaria is still a global scourge, killing mostly children in tropical regions. Developing an inexpensive vaccine that can stay stable without refrigeration has so far eluded scientists. Now, Dr. Sarel Fleishman's lab has reprogrammed proteins in such a way that they could lead to a new and effective vaccine.
Dr. Sarel Fleishman studies how proteins "mate," or fit together – and, in fact, created his own method that lets scientists change the surface of proteins so that they mate with other proteins of the researcher's choice. This technique could lead to new treatments aimed at viruses, bacteria, and cancer.
Three updates from the labs of the Weizmann Institute: discovery of a tumor suppressor gene behind a deadly form of melanoma; finding that lack of a certain protein leads to obesity, no matter the diet; and learning why plants “drive” with one foot on the brake rather than operate at full efficiency.
Our immune systems work by being able to distinguish between “self” and “invader.” Now, thanks to a team including the Weizmann Institute’s Dr. Rotem Sorek, we know that bacteria do the same – and how they do it. The Jerusalem Post explains.
Our immune systems fight bacteria – but did you know that bacteria have immune systems, too? And how does the bacterial immune system distinguish between its own DNA and that of foreign invaders, so that it knows what to fight? The answer, revealed by a Weizmann Institute and Tel Aviv University team, involves a complex, multi-stage process.
In a heart research breakthrough, Weizmann’s Prof. Eldad Tzahor and a team of researchers have induced heart cells in mice to revert to an earlier state when they can be renewed; typically, the heart is unable to heal itself. This important work could lead to powerful new treatments for heart disease.
The recent breakthrough by scientists from the Weizmann Institute and the Victor Chang Institute, where the researchers were able to regrow heart cells in mice, has made headlines around the world. As Medical Daily reports, “doctors believe they will be able to confirm in as little as five years if the technique works in humans.”
The Weizmann Institute’s Prof. Roy Bar-Ziv had a dream: creating an artificial cell that actually works like a living cell. Now, after more than a decade of “intense lab work,” his team has created the world’s first cell-on-a-chip, an exciting development with potentially game-changing applications. Israel21c reports.